Literature DB >> 19799909

Stage-specific changes in myofilament protein phosphorylation following myocardial infarction in mice.

Lori A Walker1, John S Walker, S Kelly Ambler, Peter M Buttrick.   

Abstract

The response of cardiac muscle to an insult such as myocardial infarction includes changes in the expression of numerous signaling proteins and modulation of gene expression, as well as post-translational modifications of existing proteins. Most studies to date have defined these in end-stage cardiac muscle thus obviating consideration of the temporal progression that causes the heart to transition from a compensated to a decompensated phenotype. To explore these transitions, we examined contractile protein biochemistry in a mouse MI model at two early time points: 2 days and 2 weeks post-infarct and at two later time points: 2 and 4 months post-infarct. Phosphorylation of myofilament proteins was analyzed using phosphospecific staining of polyacrylamide gels, and whenever possible, phosphospecific antibodies. Phosphorylation of myosin binding protein c, the myosin regulatory light chain and troponin I were all decreased relative to sham operated animals at both early time points. However, by 2 months, total phosphorylation of all the major myofilament proteins normalized and at both 2 and 4 months, there was a significant increase in troponin I phosphorylation. One-dimensional IEF of troponin I coupled with phospho-specific antibody analysis demonstrated a redistribution of phosphorylation sites with a significant initial decline at the putative PKA sites, Serine 22,23, and a subsequent increase at the putative PKC site, serine 43,45. These data suggest that temporal changes in myofilament protein phosphorylation contribute both to the initial compensatory hyperdynamic response to myocardial infarction and subsequently to the gradual progression to myocardial failure. (c) 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19799909      PMCID: PMC4447307          DOI: 10.1016/j.yjmcc.2009.09.010

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  41 in total

1.  Protein kinase C phosphorylation of cardiac troponin T decreases Ca(2+)-dependent actomyosin MgATPase activity and troponin T binding to tropomyosin-F-actin complex.

Authors:  T A Noland; J F Kuo
Journal:  Biochem J       Date:  1992-11-15       Impact factor: 3.857

2.  Identification of sites phosphorylated in bovine cardiac troponin I and troponin T by protein kinase C and comparative substrate activity of synthetic peptides containing the phosphorylation sites.

Authors:  T A Noland; R L Raynor; J F Kuo
Journal:  J Biol Chem       Date:  1989-12-05       Impact factor: 5.157

3.  alpha-Adrenergic response and myofilament activity in mouse hearts lacking PKC phosphorylation sites on cardiac TnI.

Authors:  David E Montgomery; Beata M Wolska; W Glen Pyle; Brian B Roman; Jasmine C Dowell; Peter M Buttrick; Alan P Koretsky; Pedro Del Nido; R John Solaro
Journal:  Am J Physiol Heart Circ Physiol       Date:  2002-06       Impact factor: 4.733

Review 4.  Developing the next generation of cardiac markers: disease-induced modifications of troponin I.

Authors:  Jason L McDonough; Jennifer E Van Eyk
Journal:  Prog Cardiovasc Dis       Date:  2004 Nov-Dec       Impact factor: 8.194

5.  Alterations in myofilament function contribute to left ventricular dysfunction in pigs early after myocardial infarction.

Authors:  J van der Velden; D Merkus; B R Klarenbeek; A T James; N M Boontje; D H W Dekkers; G J M Stienen; J M J Lamers; D J Duncker
Journal:  Circ Res       Date:  2004-11-04       Impact factor: 17.367

6.  Identification of a functionally critical protein kinase C phosphorylation residue of cardiac troponin T.

Authors:  Marius P Sumandea; W Glen Pyle; Tomoyoshi Kobayashi; Pieter P de Tombe; R John Solaro
Journal:  J Biol Chem       Date:  2003-06-28       Impact factor: 5.157

7.  Characteristics of the beta-adrenergic receptor complex in the epicardial border zone of the 5-day infarcted canine heart.

Authors:  S F Steinberg; H Zhang; E Pak; G Pagnotta; P A Boyden
Journal:  Circulation       Date:  1995-06-01       Impact factor: 29.690

8.  Phosphorylation of purified cardiac muscle C-protein by purified cAMP-dependent and endogenous Ca2+-calmodulin-dependent protein kinases.

Authors:  H C Hartzell; D B Glass
Journal:  J Biol Chem       Date:  1984-12-25       Impact factor: 5.157

9.  Diminished responsiveness to cardiac beta 1-adrenoceptor agonists in rats with chronic heart failure following myocardial infarction.

Authors:  A Sanbe; S Takeo
Journal:  Biol Pharm Bull       Date:  1995-10       Impact factor: 2.233

10.  Phosphorylation of C-protein, troponin I and phospholamban in isolated rabbit hearts.

Authors:  J L Garvey; E G Kranias; R J Solaro
Journal:  Biochem J       Date:  1988-02-01       Impact factor: 3.857

View more
  27 in total

1.  Myocardial infarction in mice alters sarcomeric function via post-translational protein modification.

Authors:  Benjamin S Avner; Krystyna M Shioura; Sarah B Scruggs; Milana Grachoff; David L Geenen; Donald L Helseth; Mariam Farjah; Paul H Goldspink; R John Solaro
Journal:  Mol Cell Biochem       Date:  2011-12-08       Impact factor: 3.396

2.  Tissue procurement strategies affect the protein biochemistry of human heart samples.

Authors:  Lori A Walker; Allen M Medway; John S Walker; Joseph C Cleveland; Peter M Buttrick
Journal:  J Muscle Res Cell Motil       Date:  2010-12-24       Impact factor: 2.698

3.  Biochemical and myofilament responses of the right ventricle to severe pulmonary hypertension.

Authors:  Lori A Walker; John S Walker; Amelia Glazier; Dale R Brown; Kurt R Stenmark; Peter M Buttrick
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-05-27       Impact factor: 4.733

Review 4.  The role of protein kinase C-mediated phosphorylation of sarcomeric proteins in the heart-detrimental or beneficial?

Authors:  Viola Kooij; Ger J M Stienen; Jolanda van der Velden
Journal:  Biophys Rev       Date:  2011-06-28

5.  Phosphorylation of protein kinase C sites Ser42/44 decreases Ca(2+)-sensitivity and blunts enhanced length-dependent activation in response to protein kinase A in human cardiomyocytes.

Authors:  Paul J M Wijnker; Vasco Sequeira; E Rosalie Witjas-Paalberends; D Brian Foster; Cristobal G dos Remedios; Anne M Murphy; Ger J M Stienen; Jolanda van der Velden
Journal:  Arch Biochem Biophys       Date:  2014-05-09       Impact factor: 4.013

6.  Independent modulation of contractile performance by cardiac troponin I Ser43 and Ser45 in the dynamic sarcomere.

Authors:  Sarah E Lang; Jennifer Schwank; Tamara K Stevenson; Mark A Jensen; Margaret V Westfall
Journal:  J Mol Cell Cardiol       Date:  2014-12-03       Impact factor: 5.000

7.  Mechanisms of favorable effects of Rho kinase inhibition on myocardial remodeling and systolic function after experimental myocardial infarction in the rat.

Authors:  Claudia Mera; Iván Godoy; Renato Ramírez; Jackeline Moya; María Paz Ocaranza; Jorge E Jalil
Journal:  Ther Adv Cardiovasc Dis       Date:  2015-10-21

8.  Characterization and validation of new tools for measuring site-specific cardiac troponin I phosphorylation.

Authors:  Stephen F Thoemmes; Crystal A Stutzke; Yanmei Du; Michael D Browning; Peter M Buttrick; Lori A Walker
Journal:  J Immunol Methods       Date:  2013-11-26       Impact factor: 2.303

9.  Myofilament incorporation and contractile function after gene transfer of cardiac troponin I Ser43/45Ala.

Authors:  Sarah E Lang; Dustin A Robinson; Helen C Wu; Todd J Herron; Philip A Wahr; Margaret V Westfall
Journal:  Arch Biochem Biophys       Date:  2013-01-11       Impact factor: 4.013

10.  Genetic ablation of interleukin-18 does not attenuate hypobaric hypoxia-induced right ventricular hypertrophy.

Authors:  Danielle R Bruns; Peter M Buttrick; Lori A Walker
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-01-08       Impact factor: 5.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.